Jackson Square Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-2,298,190
| Closed | -$206M | – | 90 |
|
|
2020
Q2 | $206M | Buy |
2,298,190
+500,447
| +28% | +$44.8M | 1.03% | 34 |
|
|
2020
Q1 | $179M | Buy |
1,797,743
+18,777
| +1% | +$1.87M | 1.13% | 32 |
|
|
2019
Q4 | $204M | Buy |
1,778,966
+62,115
| +4% | +$7.14M | 1.07% | 34 |
|
|
2019
Q3 | $217M | Sell |
1,716,851
-238,774
| -12% | -$30.1M | 1.19% | 30 |
|
|
2019
Q2 | $235M | Buy |
1,955,625
+299,949
| +18% | +$36.1M | 1.22% | 29 |
|
|
2019
Q1 | $145M | Buy |
1,655,676
+187,950
| +13% | +$16.4M | 0.79% | 35 |
|
|
2018
Q4 | $147M | Buy |
1,467,726
+28,559
| +2% | +$2.86M | 0.9% | 31 |
|
|
2018
Q3 | $165M | Buy |
1,439,167
+194,045
| +16% | +$22.2M | 0.83% | 31 |
|
|
2018
Q2 | $112M | Buy |
+1,245,122
| New | +$112M | 0.57% | 38 |
|